Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Novel Cellular Immunotherapy Using Allogeneic Vγ9/δ2-T Cells Gene-Modified to Express HTLV-1 P40Tax-Specific TCR for the Treatment of Adult T Cell Leukemia

Hiroshi Fujiwara, MD PhD, Satoshi Okumura, Yoshihiro Miyahara, Linan Wan, Isao Tawara, MD PhD, Tatsuro Jo, MD PhD, Yuetsu Tanaka, PhD, Yoshimasa Tanaka, PhD, Hiroaki Ikeda, Hiroshi Shiku

Blood (2019) 134 (Supplement_1): 3216.

https://doi.org/10.1182/blood-2019-122412

Published: 2019

Journal Articles

Uncoupling Sickle Hematopoiesis Induced Angiotensin Receptor Signaling in Sickle Nephropathy

Swarnava Roy, PhD, Parul Rai, MD, Marthe-Sandrine Eiymo Mwa Mpollo, PhD, Kyung-Hee Chang, PhD, Tilat Rizvi, Loberg Anastacia, Bruce J. Aronow, PhD, Tadashi Inagami, PhD, David Witte, MD, Jose A Cancelas, MD PhD, Punam Malik, MD

Blood (2017) 130 (Supplement 1): 440.

https://doi.org/10.1182/blood.V130.Suppl_1.440.440

Published: 2017

Journal Articles

The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A Review of 10,972 Admissions from the 2012 National Inpatient Sample

Taeha Kim, MD, Joseph Shatzel, MD, Harley Friedman, MD, Frederick Lansigan, MD

Blood (2015) 126 (23): 1314.

https://doi.org/10.1182/blood.V126.23.1314.1314

Published: 2015

Journal Articles

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

Kazushi Tanimoto, MD PhD, Hiroshi Fujiwara, MD PhD, Hiroki Tanaka, MD, Fumihiro Ochi, MD, Hiroaki Asai, MDPhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD PhD, Hiroshi Shiku, MD PhD, John Barrett, MD, Masaki Yasukawa, MD PhD

Blood (2014) 124 (21): 307.

https://doi.org/10.1182/blood.V124.21.307.307

Published: 2014

Journal Articles

A Novel β3 Intracytoplasmic Domain Mutation Associated with Macrothrombocytopenia: Structural Analysis in Comparison with Previously Reported Cases

Paquita Nurden, MD PhD, Ernest Turro, PhD, Xavier Pillois, PhD, Daniel Greene, PhD, Willem Ouwehand, MD PhD, Alan Nurden, PhD

Blood (2014) 124 (21): 1454.

https://doi.org/10.1182/blood.V124.21.1454.1454

Published: 2014

Journal Articles

Diffuse Alveolar Hemorrhage: A Life-Threatening Condition In Thrombotic Thrombocytopenic Purpura (TTP)

Lisa Thomas, MD, Qi Shi, MD, Nimesh Patel

Blood (2013) 122 (21): 4762.

https://doi.org/10.1182/blood.V122.21.4762.4762

Published: 2013

Journal Articles

Assessment Of Endothelial Damage and Cardiac Injury In a Mouse Model Mimicking Thrombotic Thrombocytopenic Purpura

Maelle Le Besnerais, Julie Favre, PhD, Cecile V. Denis, PhD, Bernard Lenormand, Paul Mulder, PhD, Lionel Nicol, PhD, Agnes Veyradier, MD PhD, Alexandra Schiviz, DVM, David G Motto, MD, PhD, Herve Levesque, MD PhD, Paul Coppo, MD PhD, Vincent Richard, PhD, Ygal Benhamou, MD

Blood (2013) 122 (21): 447.

https://doi.org/10.1182/blood.V122.21.447.447

Published: 2013

Journal Articles

Human Telomerase Reverse Transcriptase–specific T-Cell Receptor Gene Transfer Redirects T Cells to Display an Effective Antitumor Reactivity Against Adult T-Cell Leukemia

Hiroshi Fujiwara, MD, PhD, Fumihiro Ochi, Yukihiro Miyazaki, MD, Hiroaki Asai, MD, Takashi Ishida, MD, PhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2012) 120 (21): 1902.

https://doi.org/10.1182/blood.V120.21.1902.1902

Published: 2012

Journal Articles

Human Telomerase Reverse Transcriptase-Specific T-Cell Receptor Gene Transfer Redirects T-Lymphocytes to Exert Effective Antitumor Reactivity Against Adult T-Cell Leukemia,

Yukihiro Miyazaki, MD, Hiroshi Fujiwara, MD, PhD, Toshiki Ochi, MD, PhD, Hiroaki Asai, MD, Kozo Nagai, MD, Takashi Ishida, MD, PhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2011) 118 (21): 4169.

https://doi.org/10.1182/blood.V118.21.4169.4169

Published: 2011

Journal Articles

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Amane Tagashira, MD., Junichiro Takano, MD., Shotaro Hagiwara, MD., PhD., Makoto Mochizuki, MD., PhD., Hisako Endo, MD., PhD., Risen Hirai, MD., Akira Tanimura, MD., Masataka Takeshita, MD., PhD., Hirokazu Murakami, MD, PhD, Akiyoshi Miwa, MD.

Blood (2010) 116 (21): 5001.

https://doi.org/10.1182/blood.V116.21.5001.5001

Published: 2010

Journal Articles

Results from the Phase I Portion of a Phase I/II Study of ATN-224 and Bortezomib for Patients with Multiple Myeloma Relapsed from or Refractory to Bortezomib

James R. Berenson, MD, Thomas Ervin, MD, Ralph V. Boccia, MD, Olcay Batuman, MD, Regina Swift, RN, Christina DiLauro Abaya, BA, Andrew P. Mazar, PhD, Gilad S. Gordon, MD, Steven D. Reich, MD, Jennifer A. Callahan, BA

Blood (2008) 112 (11): 5185.

https://doi.org/10.1182/blood.V112.11.5185.5185

Published: 2008

Journal Articles

Early Biomarkers for the Anti-Angiogenic and Anti-Tumor Activity of the Superoxide Dismutase 1 (SOD1) Inhibitor Tetrathiomolybdate.

M.J. Braunstein, E. Smith, C. Timucin, F. Doñate, J.C. Juarez, M. Burnett, M. Manuia, D.E. Shaw, A.P. Mazar, O. Batuman

Blood (2007) 110 (11): 4214.

https://doi.org/10.1182/blood.V110.11.4214.4214

Published: 2007

Journal Articles

Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies.

James R. Berenson, MD, Ralph Vincent Boccia, MD, Asad Bashey, MD PhD, Alexandra M. Levine, MD, Omer N. Koc, MD, Jennifer A. Callahan, Andrew P. Mazar, PhD, Steven D. Reich, MD

Blood (2006) 108 (11): 2593.

https://doi.org/10.1182/blood.V108.11.2593.2593

Published: 2006

Journal Articles

The Role of Calcium/Calmodulin-Dependent Protein Kinase Cascade on MIP-1α Gene Expression in ATL Cells.

Kensuke Matsumoto, MD, Koji Murao, MD, PhD, Hitomi Imachi, MD, PhD, Takamasa Nishiuchi, MD, Hiroaki Ohnishi, MD, PhD, Toshihiko Ishida, MD, PhD

Blood (2006) 108 (11): 3877.

https://doi.org/10.1182/blood.V108.11.3877.3877

Published: 2006

Journal Articles

Crystal Structure of the Interaction of Human Urokinase Plasminogen Activitor with Its Receptor.

Qing Huai, PhD, Andrew P. Mazar, Ph.D, Graham Parry, Ph.D, Alice Kuo, Douglas B. Cines, MD, Yongdong Li, Cai Yuan, Chuanbing Bian, Liqing Chen, Ph.D, Bruce Furie, MD, Barbara C. Furie, Ph.D, Mingdong Huang, Ph.D

Blood (2005) 106 (11): 683.

https://doi.org/10.1182/blood.V106.11.683.683

Published: 2005

NARROW

Novel Cellular Immunotherapy Using Allogeneic Vγ9/δ2-T Cells Gene-Modified to Express HTLV-1 P40Tax-Specific TCR for the Treatment of Adult T Cell Leukemia

Uncoupling Sickle Hematopoiesis Induced Angiotensin Receptor Signaling in Sickle Nephropathy

The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A Review of 10,972 Admissions from the 2012 National Inpatient Sample

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

A Novel β3 Intracytoplasmic Domain Mutation Associated with Macrothrombocytopenia: Structural Analysis in Comparison with Previously Reported Cases

Diffuse Alveolar Hemorrhage: A Life-Threatening Condition In Thrombotic Thrombocytopenic Purpura (TTP)

Assessment Of Endothelial Damage and Cardiac Injury In a Mouse Model Mimicking Thrombotic Thrombocytopenic Purpura

Human Telomerase Reverse Transcriptase–specific T-Cell Receptor Gene Transfer Redirects T Cells to Display an Effective Antitumor Reactivity Against Adult T-Cell Leukemia

Human Telomerase Reverse Transcriptase-Specific T-Cell Receptor Gene Transfer Redirects T-Lymphocytes to Exert Effective Antitumor Reactivity Against Adult T-Cell Leukemia,

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Results from the Phase I Portion of a Phase I/II Study of ATN-224 and Bortezomib for Patients with Multiple Myeloma Relapsed from or Refractory to Bortezomib

Early Biomarkers for the Anti-Angiogenic and Anti-Tumor Activity of the Superoxide Dismutase 1 (SOD1) Inhibitor Tetrathiomolybdate.

Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies.

The Role of Calcium/Calmodulin-Dependent Protein Kinase Cascade on MIP-1α Gene Expression in ATL Cells.

Crystal Structure of the Interaction of Human Urokinase Plasminogen Activitor with Its Receptor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only